shot-button
E-paper E-paper
Home > News > India News > Article > COVID 19 Pharma companies slash Remdesivir injection prices after govt intervention

COVID-19: Pharma companies slash Remdesivir injection prices after govt intervention

Updated on: 18 April,2021 09:43 AM IST  |  New Delhi
ANI |

The announcement comes days after the Central government held a meeting with all existing manufacturers of the drug and other stakeholders in order to discuss steps taken to increase production and supply and reduce prices of Remdesivir.

COVID-19: Pharma companies slash Remdesivir injection prices after govt intervention

Representational Image | File Pic

Amid the shortage of the anti-viral drug Remdesivir in the wake of spike in COVID-19 infections in the country, seven major pharmaceutical companies have reduced the maximum retail price (MRP) of the drug on the intervention of the Union government.


The announcement comes days after the Central government held a meeting with all existing manufacturers of the drug and other stakeholders in order to discuss steps taken to increase production and supply and reduce prices of Remdesivir.


In an office memorandum issued on Saturday, the Ministry of Chemicals and Fertilizers said, "with reference to the ongoing efforts for enhancement of availability and affordability of 'Remdesivir' injection. On the intervention of the government, the major manufacturers/marketers of 'Remdesivir injection' have reported voluntary reduction in maximum retail price (MRP)."


As per the revised price of major brands of Remdesivir injection 100mg/Vial', Cadila Healthcare Ltd's REMDAC which was earlier available at Rs 2,800 have been reduced to Rs 899. The price of Syngene International Ltd's RemWin is reduced to Rs 2,450 from Rs 3,950. Dr Reddy's Laboratories Ltd's REDYX will be available at Rs 2,700 instead of Rs 5,400. Cipla Ltd's CIPREMI will now be available at Rs 3,000 instead of Rs 4,000, Maylan Pharmaceuticals Pvt Ltd's DESREM will be available at Rs 3400 instead of Rs 4,800, Jubilant Generics Ltd's JUBI-R will be available at Rs 3,400 instead of Rs 4,700 and Hetero Healthcare Ltd's COVIFOR will be available at Rs 3,490 instead of Rs 5,400.

Informing about the reduced price, Union Minister of State for Chemicals and Fertiliser Mansukh Mandaviya in a tweet thanks pharmaceutical companies for joining hands with the government in the fight against COVID-19.

"Due to Government's intervention, the price of #RemdesivirInjection is now reduced! I am thankful to pharmaceutical companies for joining hands with the Government to fight against COVID Pandemic," he tweeted.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK